Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

AIDS

Volumn 15, Issue 16, 2001, Pages 2109-2117

  Gross, Robert ^a   Bilker, Warren B ^a   Friedman, Harvey M ^a   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adherence; Antiretroviral therapy; CD4 cell count; Nelfinavir; Protease inhibitors; Viral load

Indexed keywords

CD4 ANTIGEN; NELFINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DOSE CALCULATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEINASE INHIBITION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; VIRUS LOAD;

ADULT; AGED; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD;

EID: 0035834532     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200111090-00006     Document Type: Article

References (34)

1. Report of the NIH Panel to define principles of therapy of HIV infection
2. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
3. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy
4. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
5. Adherence: A necessity for successful HIV combination therapy
6. Adherence in AIDS clinical trials: A framework for clinical research and clinical care
7. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management. International AIDS Society-USA Panel
8. Public health implications of antiretroviral therapy and HIV drug resistance
9. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilege (Agence Nationale de Recherches sur le SIDA 072) Study Team)
10. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens
11. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group
12. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
13. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
14. Magnitude and nature of noncompliance with treatment using isosorbide dinitrate in patients with ischemic heart disease
15. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: A comparative study
16. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens
17. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial
18. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator
19. Compliance assessed by the Medication Event Monitoring System
20. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care
21. Comparing compliance patterns between randomized treatments
22. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel
23. Patient compliance and drug failure in protease inhibitor monotherapy
24. The meaning and use of the area under a receiver operating characteristic (ROC) curve
25. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
26. LMSMVE: A program for least median of squares regression and robust distances
27. Test for interaction in epidemiologic studies: A review and a study of power
28. Power and sample size calculations: A review and computer program
29. Decay characteristics of HIV-1-infected compartments during combination therapy
30. Potential utility of electronic drug compliance monitoring in measures of adverse outcomes associated with immunosuppressive agents
31. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease
32. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG)